FELERAZ Trademark

Trademark Overview

On Tuesday, August 16, 2011, a trademark application was filed for FELERAZ with the United States Patent and Trademark Office. The USPTO has given the FELERAZ trademark a serial number of 85398995. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 28, 2014. This trademark is owned by Aegerion Pharmaceuticals, Inc.. The FELERAZ trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

PHARMACEUTICAL RESEARCH AND DEVELOPMENT IN THE FIELD OF CARDIOVASCULAR DISEASE, IN PARTICULAR, HYPERLIPIDEMIA
feleraz

General Information

Serial Number85398995
Word MarkFELERAZ
Filing DateTuesday, August 16, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 28, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 31, 2012

Trademark Statements

Goods and ServicesPHARMACEUTICAL RESEARCH AND DEVELOPMENT IN THE FIELD OF CARDIOVASCULAR DISEASE, IN PARTICULAR, HYPERLIPIDEMIA

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, June 7, 2012
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAegerion Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameAegerion Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Monday, April 28, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, April 28, 2014ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 1, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, September 28, 2013EXTENSION 2 GRANTED
Wednesday, September 25, 2013EXTENSION 2 FILED
Wednesday, September 25, 2013TEAS EXTENSION RECEIVED
Thursday, April 11, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 10, 2013EXTENSION 1 GRANTED
Thursday, March 21, 2013EXTENSION 1 FILED
Wednesday, April 10, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 21, 2013TEAS EXTENSION RECEIVED
Tuesday, September 25, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 31, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 31, 2012PUBLISHED FOR OPPOSITION
Wednesday, July 11, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 28, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 27, 2012ASSIGNED TO LIE
Friday, June 8, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 7, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 7, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 7, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 8, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 8, 2011NON-FINAL ACTION E-MAILED
Thursday, December 8, 2011NON-FINAL ACTION WRITTEN
Wednesday, December 7, 2011ASSIGNED TO EXAMINER
Friday, August 19, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM

Related Keywords

feleraz disease particular hyperlipidemia cardiovascular field research development pharmaceutical